Transmedics Group Inc
TMDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.9B
Close$
$86.08
4% downside
Current Fair Value
4% downsideOvervalued by 4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.90 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.6 |
| Beta | 1.88 |
| Outstanding Shares | 34,579,980 |
Return
| Return on Equity | 29.28% |
|---|---|
| Return on Assets | 10.36% |
| Return on Invested Capital | 6.69% |
Valuation & Multiples
| P/E Ratio | 18.98 |
|---|---|
| PEG | -32.76 |
| Price to Sales | 4.72 |
| Price to Book Ratio | 6.4 |
| Enterprise Value to Revenue | 4.93 |
| Enterprise Value to EBIT | 36.06 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.50
Average shareholder expectationRevenue Estimate
$184.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.32
Average shareholder expectationRevenue Estimate
$177.03 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3027▼ 54.77% |
|---|---|
| Total Calls | 18,500▼ 96.77% |
| Total Puts | 5,600▼ 98.85% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 32.63%▼ 73.35% |
|---|---|
| Total Invested | $745.47M▼ 79.42% |
| Investors Holding | 171▼ 262.00% |
ESG Score
No data